Glassdoor on Tuesday released its annual Employees' Choice Awards list, which recognizes CEOs who have received the highest employee ratings on the career website. Across large, medium, and small organizations, 31 health care CEOs made the cut.
Though rates of routine childhood vaccinations have significantly rebounded after dropping precipitously in the early days of Covid-19, they are still far short of pre-pandemic levels—and, if not addressed, could pose "a serious public health threat," according to a recent Morbidity and Mortality Weekly Report from CDC.
HHS on Thursday announced it is investing more than $3 billion into the discovery, development, and manufacturing of antiviral drugs to treat early-stage Covid-19—although Anthony Fauci, the chief medical advisor for the White House's Covid-19 response, warned that "we've never hit a home run the first time at bat" with antiviral drugs.
The Biden administration buys an additional 200 million Moderna Covid-19 vaccine doses, a new study suggests the coronavirus may have arrived in the United States weeks prior to the first documented case, and more.
U.S. District Judge Leonard Stark on Wednesday denied HHS' request to dismiss a lawsuit from AstraZeneca challenging an advisory opinion that prevents drugmakers from restricting sales to contract pharmacies under the 340B program, in today's bite-sized hospital and health industry news from California, Delaware, and Georgia.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.